Review

Linus Pauling Institute, Department of Biochemisty & Biophysics, Oregon State University, 2011 ALS Bldg, Corvallis, OR 97331-7305, USA.

Email the corresponding author at adrian.gombart@oregonstate.edu

Published Online:6 Nov 2009https://doi.org/10.2217/fmb.09.87

View article

Abstract

Vitamin D deficiency has been correlated with increased rates of infection. Since the early 19th century, both environmental (i.e., sunlight) and dietary sources (cod liver) of vitamin D have been identified as treatments for TB. The recent discovery that vitamin D induces antimicrobial peptide gene expression explains, in part, the ‘antibiotic’ effect of vitamin D and has greatly renewed interest in the ability of vitamin D to improve immune function. Subsequent work indicates that this regulation is biologically important for the response of the innate immune system to wounds and infection and that deficiency may lead to suboptimal responses toward bacterial and viral infections. The regulation of the cathelicidin antimicrobial peptide gene is a human/primate-specific adaptation and is not conserved in other mammals. The capacity of the vitamin D receptor to act as a high-affinity receptor for vitamin D and a low-affinity receptor for secondary bile acids and potentially other novel nutritional compounds suggests that the evolutionary selection to place the cathelicidin gene under control of the vitamin D receptor allows for its regulation under both endocrine and xenobiotic response systems. Future studies in both humans and humanized mouse models will elucidate the importance of this regulation and lead to the development of potential therapeutic applications.

Keywords:

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

1 Bikle D: Nonclassic actions of vitamin D.J. Clin. Endocrinol. Metab.94(1),26–34 (2009).
Medline CASGoogle Scholar
2 Holick MF, Chen TC: Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr.87(4),1080S–1086S (2008).
Medline CASGoogle Scholar
3 Mangelsdorf DJ, Thummel C, Beato M et al.: The nuclear receptor superfamily: the second decade. Cell83(6),835–839 (1995).▪ Excellent review on nuclear receptors.
Medline CASGoogle Scholar
4 Christakos S, Raval-Pandya M, Wernyj RP, Yang W: Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D₃. Biochem. J.316(Pt 2),361–371 (1996).
Medline CASGoogle Scholar
5 Bouillon R, Garmyn M, Verstuyf A, Segaert S, Casteels K, Mathieu C: Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. Eur. J. Endocrinol.133(1),7–16 (1995).
Medline CASGoogle Scholar
6 James SY, Williams MA, Newland AC, Colston KW: Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen. Pharmacol.32(1),143–154 (1999).
Medline CASGoogle Scholar
7 Zierold C, Darwish HM, Deluca HF: Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J. Biol. Chem.270(4),1675–1678 (1995).
Medline CASGoogle Scholar
8 Ren S, Nguyen L, Wu S, Encinas C, Adams JS, Hewison M: Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J. Biol. Chem.280(21),20604–20611 (2005).
Medline CASGoogle Scholar
9 Provvedini D, Tsoukas C, Deftos L, Manolagas S: 1,25-dihydroxyvitamin D₃ receptors in human leukocytes. Science221(4616),1181–1183 (1983).
Medline CASGoogle Scholar
10 Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM: Specific high-affinity receptors for 1,25-dihydroxyvitamin D₃ in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab.57(6),1308–1310 (1983).
Medline CASGoogle Scholar
11 Deluca HF, Cantorna MT: Vitamin D: its role and uses in immunology. FASEB J.15(14),2579–2585 (2001).
Medline CASGoogle Scholar
12 Adorini L, Giarratana N, Penna G: Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol.16(2),127–134 (2004).
Medline CASGoogle Scholar
13 Lemire JM, Archer DC, Beck L, Spiegelberg HL: Immunosuppressive actions of 1,25-dihydroxyvitamin D₃: preferential inhibition of Th1 functions. J. Nutr.125(Suppl. 6),1704S–1708S (1995).
Medline CASGoogle Scholar
14 Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A: 1α,25-dihydroxyvitamin D₃ has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J. Immunol.167(9),4974–4980 (2001).
Medline CASGoogle Scholar
15 Penna G, Adorini L: 1α,25-dihydroxyvitamin D₃ inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol.164(5),2405–2411 (2000).
Medline CASGoogle Scholar
16 Staeva-Vieira TP, Freedman LP: 1,25-dihydroxyvitamin D₃ inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J. Immunol.168(3),1181–1189 (2002).
Medline CASGoogle Scholar
17 Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM: Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther.324(1),23–33 (2008).
Medline CASGoogle Scholar
18 Adorini L, Penna G: Dendritic cell tolerogenicity in immunomodulation by vitamin D receptor agonists. Hum. Immunol. (2009) (Epub ahead of print).
MedlineGoogle Scholar
19 Adorini L, Penna G: Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum. Immunol.70(5),345–352 (2009).
Medline CASGoogle Scholar
20 Adorini L, Penna G, Giarratana N et al.: Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands. J. Steroid Biochem. Mol. Biol.89–90(1–5),437–441 (2004).
MedlineGoogle Scholar
21 Adorini L: Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol.233(2),115–124 (2005).
Medline CASGoogle Scholar
22 Mathieu C, Adorini L: The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol. Med.8(4),174–179 (2002).
Medline CASGoogle Scholar
23 Adorini L, Penna G: Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol.4(8),404–412 (2008).
Medline CASGoogle Scholar
24 Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE: Modulatory effects of 1,25-dihydroxyvitamin D₃ on human B cell differentiation. J. Immunol.179(3),1634–1647 (2007).
Medline CASGoogle Scholar
25 Liu PT, Stenger S, Li H et al.: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science311(5768),1770–1773 (2006).▪▪ Demonstrated vitamin D-dependent activation of cathelicidin by Toll-like receptor signaling and established importance of vitamin D induction of cathelicidin in response to Mycobacterium tuberculosis.
Medline CASGoogle Scholar
26 Overbergh L, Decallonne B, Waer M et al.: 1α,25-dihydroxyvitamin D₃ induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524–543). Diabetes49(8),1301–1307 (2000).
Medline CASGoogle Scholar
27 Koeffler HP, Reichel H, Bishop JE, Norman AW: γ-interferon stimulates production of 1,25-dihydroxyvitamin D₃ by normal human macrophages. Biochem. Biophys. Res. Commun.127(2),596–603 (1985).
Medline CASGoogle Scholar
28 Hewison M, Kantorovich V, Liker HR et al.: Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J. Bone Miner. Res.18(3),579–582 (2003).
MedlineGoogle Scholar
29 Cadranel J, Hance AJ, Milleron B, Paillard F, Akoun GM, Garabedian M: Vitamin D metabolism in tuberculosis. Production of 1,25(OH)₂D₃ by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. Am. Rev. Respir. Dis.138(4),984–989 (1988).
Medline CASGoogle Scholar
30 Reichel H, Koeffler HP, Norman AW: Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D₃ by interferon-γ-stimulated normal human bone marrow and alveolar macrophages. J. Biol. Chem.262(23),10931–10937 (1987).
Medline CASGoogle Scholar
31 Yu XP, Bellido T, Manolagas SC: Down-regulation of NF-κb protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D₃. Proc. Natl Acad. Sci. USA92(24),10990–10994 (1995).
Medline CASGoogle Scholar
32 Harant H, Andrew PJ, Reddy GS, Foglar E, Lindley IJ: 1α,25-dihydroxyvitamin D₃ and a variety of its natural metabolites transcriptionally repress nuclear-factor-κb-mediated interleukin-8 gene expression. Eur. J. Biochem.250(1),63–71 (1997).
Medline CASGoogle Scholar
33 Sun J, Kong J, Duan Y et al.: Increased NF-κb activity in fibroblasts lacking the vitamin D receptor. Am. J. Physiol. Endocrinol. Metab.291(2),E315–E322 (2006).
Medline CASGoogle Scholar
34 Van Etten E, Mathieu C: Immunoregulation by 1,25-dihydroxyvitamin D₃: basic concepts. J. Steroid Biochem. Mol. Biol.97(1–2),93–101 (2005).
Medline CASGoogle Scholar
35 Rajapakse R, Mousli M, Pfaff AW et al.: 1,25-dihydroxyvitamin D₃ induces splenocyte apoptosis and enhances BALB/C mice sensitivity to toxoplasmosis. J. Steroid Biochem. Mol. Biol.96(2),179–185 (2005).
Medline CASGoogle Scholar
36 Ehrchen J, Helming L, Varga G et al.: Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J.21(12),3208–3218 (2007).
Medline CASGoogle Scholar
37 Martineau AR, Wilkinson KA, Newton SM et al.: IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol.178(11),7190–7198 (2007).▪ Provided further evidence that induction of cathelicidin is important for suppression of M. tuberculosis growth.
Medline CASGoogle Scholar
38 Gombart AF, Borregaard N, Koeffler HP: Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D₃. FASEB J.19(9),1067–1077 (2005).▪▪ One of the first papers to demonstrate induction of cathelicidin by vitamin D particularly in macrophages.
Medline CASGoogle Scholar
39 Wang TT, Nestel FP, Bourdeau V et al.: Cutting edge: 1,25-dihydroxyvitamin D₃ is a direct inducer of antimicrobial peptide gene expression. J. Immunol.173(5),2909–2912 (2004).▪ First report of vitamin D inducing cathelicidin and defensin β2/DEFB4.
Medline CASGoogle Scholar
40 Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjo A, Torma H, Stahle M: Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Invest. Dermatol.124(5),1080–1082 (2005).▪▪ First report showing that topical application of vitamin D induces cathelicidin in human skin.
Medline CASGoogle Scholar
41 Zasloff M: Fighting infections with vitamin D. Nat. Med.12(4),388–390 (2006).
Medline CASGoogle Scholar
42 Gombart AF, O’Kelly J, Saito T, Koeffler HP: Regulation of the CAMP gene by 1,25(OH)₂D₃ in various tissues. J. Steroid Biochem. Mol. Biol.103(3–5),552–557 (2007).
Medline CASGoogle Scholar
43 Schauber J, Dorschner RA, Coda AB et al.: Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest.117(3),803–811 (2007).▪▪ Demonstrates that Toll-like receptor induction of cathelicidin in wounded skin requires a vitamin D pathway.
Medline CASGoogle Scholar
44 Liu PT, Schenk M, Walker VP et al.: Convergence of IL-1β and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One4(6),e5810 (2009).▪▪ Demonstrates the importance of convergent signaling pathways to induce defensin β2/DEFB4 by the vitamin D pathway.
MedlineGoogle Scholar
45 Zanetti M, Gennaro R, Romeo D: Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett.374(1),1–5 (1995).
Medline CASGoogle Scholar
46 Sorensen OE, Follin P, Johnsen AH et al.: Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood97(12),3951–3959 (2001).
Medline CASGoogle Scholar
47 Lehrer RI, Ganz T: Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol.9(1),18–22 (2002).
MedlineGoogle Scholar
48 Zanetti M, Gennaro R, Scocchi M, Skerlavaj B: Structure and biology of cathelicidins. Adv. Exp. Med. Biol.479,203–218 (2000).
Medline CASGoogle Scholar
49 Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun.67(5),2561–2566 (1999).
Medline CASGoogle Scholar
50 Bals R, Wang X, Zasloff M, Wilson JM: The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl Acad. Sci. USA95(16),9541–9546 (1998).
Medline CASGoogle Scholar
51 Murakami M, Ohtake T, Dorschner RA, Gallo RL: Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J. Dent. Res.81(12),845–850 (2002).
Medline CASGoogle Scholar
52 Murakami M, Ohtake T, Dorschner RA, Schittek B, Garbe C, Gallo RL: Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol.119(5),1090–1095 (2002).
Medline CASGoogle Scholar
53 Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH: Fall-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl Acad. Sci. USA92(1),195–199 (1995).
Medline CASGoogle Scholar
54 Malm J, Sorensen O, Persson T et al.: The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect. Immun.68(7),4297–4302 (2000).
Medline CASGoogle Scholar
55 Hammami-Hamza S, Doussau M, Bernard J et al.: Cloning and sequencing of SOB3, a human gene coding for a sperm protein homologous to an antimicrobial protein and potentially involved in zona pellucida binding. Mol. Hum. Reprod.7(7),625–632 (2001).
Medline CASGoogle Scholar
56 Andersson E, Sorensen OE, Frohm B, Borregaard N, Egesten A, Malm J: Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Hum. Reprod.17(10),2529–2534 (2002).
Medline CASGoogle Scholar
57 Agerberth B, Charo J, Werr J et al.: The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood96(9),3086–3093 (2000).
Medline CASGoogle Scholar
58 Di Nardo A, Vitiello A, Gallo RL: Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol.170(5),2274–2278 (2003).
Medline CASGoogle Scholar
59 Sorensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N: The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood90(7),2796–2803 (1997).
Medline CASGoogle Scholar
60 Dorschner RA, Pestonjamasp VK, Tamakuwala S et al.: Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol.117(1),91–97 (2001).
Medline CASGoogle Scholar
61 Ong PY, Ohtake T, Brandt C et al.: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med.347(15),1151–1160 (2002).
Medline CASGoogle Scholar
62 Frohm M, Agerberth B, Ahangari G et al.: The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem.272(24),15258–15263 (1997).
Medline CASGoogle Scholar
63 Nizet V, Ohtake T, Lauth X et al.: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature414(6862),454–457 (2001).▪▪ Development of cathelicidin knockout mouse and demonstration of its susceptibility to skin infection.
Medline CASGoogle Scholar
64 Chromek M, Slamova Z, Bergman P et al.: The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med.12(6),636–641 (2006).
Medline CASGoogle Scholar
65 Putsep K, Carlsson G, Boman HG, Andersson M: Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet360(9340),1144–1149 (2002).
Medline CASGoogle Scholar
66 Gombart AF, Koeffler HP: Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor c/ebp(e). Curr. Opin. Hematol.9(1),36–42 (2002).
MedlineGoogle Scholar
67 Yang YH, Zheng GG, Li G, Zhang B, Song YH, Wu KF: Expression of LL-37/hCAP-18 gene in human leukemia cells. Leuk. Res.27(10),947–950 (2003).
Medline CASGoogle Scholar
68 Ganz T: Defensins: antimicrobial peptides of vertebrates. C. R. Biol.327(6),539–549 (2004).
Medline CASGoogle Scholar
69 Davies PD: A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle66(4),301–306 (1985).
Medline CASGoogle Scholar
70 Wilkinson RJ, Llewelyn M, Toossi Z et al.: Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case–control study. Lancet355(9204),618–621 (2000).
Medline CASGoogle Scholar
71 Nnoaham KE, Clarke A: Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol.37(1),113–119 (2008).
MedlineGoogle Scholar
72 Rook GA, Steele J, Fraher L et al.: Vitamin D₃, γ-interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology57(1),159–163 (1986).
Medline CASGoogle Scholar
73 Liu PT, Stenger S, Tang DH, Modlin RL: Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol.179(4),2060–2063 (2007).▪ Uses siRNA approaches to demonstrate that antimycobacterial activity induced by vitamin D is due, in part, to cathelicidin expression.
Medline CASGoogle Scholar
74 Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ: Vitamin D in the treatment of pulmonary tuberculosis. J. Steroid Biochem. Mol. Biol.103(3–5),793–798 (2007).
Medline CASGoogle Scholar
75 Nursyam EW, Amin Z, Rumende CM: The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med. Indones.38(1),3–5 (2006).
MedlineGoogle Scholar
76 Morcos MM, Gabr AA, Samuel S et al.: Vitamin D administration to tuberculous children and its value. Boll. Chim. Farm.137(5),157–164 (1998).
Medline CASGoogle Scholar
77 Martineau AR, Wilkinson RJ, Wilkinson KA et al.: A single dose of vitamin D enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med.176(2),208–213 (2007).
Medline CASGoogle Scholar
78 Wejse C, Gomes VF, Rabna P et al.: Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med.179(9),843–850 (2009).
Medline CASGoogle Scholar
79 Martineau AR, Nanzer AM, Satkunam KR et al.: Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients. Int. J. Tuberc. Lung Dis.13(1),119–125 (2009).
Medline CASGoogle Scholar
80 Laaksi I, Ruohola JP, Tuohimaa P et al.: An association of serum vitamin D concentrations < 40 nmol/l with acute respiratory tract infection in young Finnish men. Am. J. Clin. Nutr.86(3),714–717 (2007).
Medline CASGoogle Scholar
81 Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A: Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur. J. Clin. Nutr.63(4),473–477 (2009).
Medline CASGoogle Scholar
82 Walker VP, Modlin RL: The vitamin D connection to pediatric infections and immune function. Pediatr. Res. (2009) (Epub ahead of print).
Google Scholar
83 Ginde AA, Mansbach JM, Camargo CA Jr: Vitamin D, respiratory infections, and asthma. Curr. Allergy Asthma Rep.9(1),81–87 (2009).
Medline CASGoogle Scholar
84 Cannell JJ, Vieth R, Umhau JC et al.: Epidemic influenza and vitamin D. Epidemiol. Infect.134(6),1129–1140 (2006).
Medline CASGoogle Scholar
85 Bodnar LM, Krohn MA, Simhan HN: Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J. Nutr.139(6),1157–1161 (2009).
Medline CASGoogle Scholar
86 Villamor E: A potential role for vitamin D on HIV infection? Nutr. Rev.64(5 Pt 1),226–233 (2006).
MedlineGoogle Scholar
87 Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW: Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J. Immunol.181(10),7090–7099 (2008).
Medline CASGoogle Scholar
88 Gombart AF, Saito T, Koeffler HP: Exapation of an ancient ALU short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics10(1),321 (2009).▪▪ Demonstrated that vitamin D regulation of cathelicidin is human/primate specific and conserved during for 50–60 million years of primate evolution.
MedlineGoogle Scholar
89 Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF: Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun.70(2),953–963 (2002).
Medline CASGoogle Scholar
90 Erdag G, Morgan JR: Interleukin-1α and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann. Surg.235(1),113–124 (2002).
MedlineGoogle Scholar
91 Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N: Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol.170(11),5583–5589 (2003).
Medline CASGoogle Scholar
92 Schauber J, Svanholm C, Termen S et al.: Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut52(5),735–741 (2003).
Medline CASGoogle Scholar
93 Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL: Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology118(4),509–519 (2006).
Medline CASGoogle Scholar
94 Islam D, Bandholtz L, Nilsson J et al.: Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med.7(2),180–185 (2001).
Medline CASGoogle Scholar
95 Chakraborty K, Ghosh S, Koley H et al.: Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human β-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell Microbiol.10(12),2520–2537 (2008).
Medline CASGoogle Scholar
96 Vieth R: What is the optimal vitamin D status for health? Prog. Biophys. Mol. Biol.92(1),26–32 (2006).
Medline CASGoogle Scholar
97 Adams JS, Ren S, Liu PT et al.: Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol.182(7),4289–4295 (2009).▪ Proposes that vitamin D regulation may prevent pathogen-mediated repression of cathelicidin gene expression.
Medline CASGoogle Scholar
98 Krutzik SR, Hewison M, Liu PT et al.: IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol.181(10),7115–7120 (2008).▪ Provides evidence that implicates cytokine expression important in vitamin D-mediated induction of cathelicidin.
Medline CASGoogle Scholar
99 Lande R, Gregorio J, Facchinetti V et al.: Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature449(7162),564–569 (2007).
Medline CASGoogle Scholar
100 Ganguly D, Chamilos G, Lande R et al.: Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med.206(9),1983–1994 (2009).
Medline CASGoogle Scholar
101 Peric M, Koglin S, Kim SM et al.: IL-17α enhances vitamin D₃-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J. Immunol.181(12),8504–8512 (2008).
Medline CASGoogle Scholar
102 Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R: IL-22 increases the innate immunity of tissues. Immunity21(2),241–254 (2004).
Medline CASGoogle Scholar
103 Kao CY, Chen Y, Thai P et al.: IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-κb signaling pathways. J. Immunol.173(5),3482–3491 (2004).
Medline CASGoogle Scholar
104 Peric M, Koglin S, Dombrowski Y et al.: Vitamin D analogs differentially control antimicrobial peptide/“Alarmin” expression in psoriasis. PLoS One4(7),e6340 (2009).
MedlineGoogle Scholar
105 Buchau AS, Macleod DT, Morizane S, Kotol PF, Hata T, Gallo RL: Bcl-3 acts as an innate immune modulator by controlling antimicrobial responses in keratinocytes. J. Invest. Dermatol.129(9),2148–2155 (2009).
Medline CASGoogle Scholar
106 Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ: Nuclear receptors and lipid physiology: opening the X-files. Science294(5548),1866–1870 (2001).
Medline CASGoogle Scholar
107 Schmidt DR, Mangelsdorf DJ: Nuclear receptors of the enteric tract: guarding the frontier. Nutr. Rev.66(10 Suppl. 2),S88–S97 (2008).▪ Excellent review of nuclear receptors and protection of the digestive system.
MedlineGoogle Scholar
108 Makishima M, Okamoto AY, Repa JJ et al.: Identification of a nuclear receptor for bile acids. Science284(5418),1362–1365 (1999).▪▪ First evidence that lithocholic acid is a ligand for the vitamin D receptor.
Medline CASGoogle Scholar
109 Adachi R, Honma Y, Masuno H et al.: Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J. Lipid Res.46(1),46–57 (2005).
Medline CASGoogle Scholar
110 Staudinger JL, Goodwin B, Jones SA et al.: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl Acad. Sci. USA98(6),3369–3374 (2001).
Medline CASGoogle Scholar
111 Xie W, Radominska-Pandya A, Shi Y et al.: An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl Acad. Sci. USA98(6),3375–3380 (2001).
Medline CASGoogle Scholar
112 Matsubara T, Yoshinari K, Aoyama K et al.: Role of vitamin D receptor in the lithocholic acid-mediated CYP3a induction in vitro and in vivo. Drug Metab. Dispos.36(10),2058–2063 (2008).
Medline CASGoogle Scholar
113 Ogura M, Nishida S, Ishizawa M et al.: Vitamin D₃ modulates the expression of bile acid regulatory genes and represses inflammation in bile duct-ligated mice. J. Pharmacol. Exp. Ther.328(2),564–570 (2009).
Medline CASGoogle Scholar
114 Lorenzo-Zuniga V, Bartoli R, Planas R et al.: Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology37(3),551–557 (2003).
Medline CASGoogle Scholar
115 Inagaki T, Moschetta A, Lee YK et al.: Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl Acad. Sci. USA103(10),3920–3925 (2006).
Medline CASGoogle Scholar
116 D’aldebert E, Biyeyeme Bi Mve MJ, Mergey M et al.: Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology136(4),1435–1443 (2009).
MedlineGoogle Scholar
117 Schwab M, Reynders V, Shastri Y, Loitsch S, Stein J, Schroder O: Role of nuclear hormone receptors in butyrate-mediated up-regulation of the antimicrobial peptide cathelicidin in epithelial colorectal cells. Mol. Immunol.44(8),2107–2114 (2007).
Medline CASGoogle Scholar
118 Jurutka PW, Bartik L, Whitfield GK et al.: Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J. Bone Miner. Res.22(Suppl. 2),V2–V10 (2007).
Medline CASGoogle Scholar
119 Jacobsen F, Mittler D, Hirsch T et al.: Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther.12(20),1494–1502 (2005).
Medline CASGoogle Scholar
120 Raqib R, Sarker P, Bergman P et al.: Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc. Natl Acad. Sci. USA103(24),9178–9183 (2006).
Medline CASGoogle Scholar
121 Zasloff M: Inducing endogenous antimicrobial peptides to battle infections. Proc. Natl Acad. Sci. USA103(24),8913–8914 (2006).
Medline CASGoogle Scholar
122 Gombart AF, Bhan I, Borregaard N et al.: Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin. Infect. Dis.48(4),418–424 (2009).▪▪ First paper to demonstrate that circulating cathelicidin may provide protection from infection and/or sepsis.
Medline CASGoogle Scholar
123 Jeng L, Yamshchikov AV, Judd SE et al.: Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J. Transl. Med.7,28 (2009).
MedlineGoogle Scholar
124 Hata TR, Kotol P, Jackson M et al.: Administration of oral vitamin D induces cathelicidin production in atopic individuals. J. Allergy Clin. Immunol.122(4),829–831 (2008).
Medline CASGoogle Scholar
125 Oppenheim JJ, Tewary P, De La Rosa G, Yang D: Alarmins initiate host defense. Adv. Exp. Med. Biol.601,185–194 (2007).
MedlineGoogle Scholar
126 Yang D, De La Rosa G, Tewary P, Oppenheim JJ: Alarmins link neutrophils and dendritic cells. Trends Immunol. (2009) (Epub ahead of print).
Google Scholar
127 Nehring JA, Zierold C, Deluca HF: Lithocholic acid can carry out in vivo functions of vitamin D. Proc. Natl Acad. Sci. USA104(24),10006–10009 (2007).
Medline CASGoogle Scholar
128 Ishizawa M, Matsunawa M, Adachi R et al.: Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J. Lipid Res.49(4),763–772 (2008).
Medline CASGoogle Scholar
129 Holick MF: The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol. Aspects Med.29(6),361–368 (2008).
Medline CASGoogle Scholar

Vol. 4, No. 9

Metrics

Downloaded 634 times

History

Published online 6 November 2009

Published in print November 2009

Information

Keywords

Acknowledgements

The author would like to thank members of the laboratory for their useful discussions and apologizes to those authors whose interesting data could not be included owing to space constraints.

Financial & competing interests disclosure

This work was supported by grant 5R01AI065604–04 to the author from the National Institute of Allergy and Infectious Diseases at the NIH. The author has received a patent covering the use of vitamin D and its analogs to induce the cathelicidin gene. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

PDF download

The vitamin D–antimicrobial peptide pathway and its role in protection against infection

Abstract

Bibliography